OWCP — OWC Pharmaceutical Research Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$1.46m
Annual balance sheet for OWC Pharmaceutical Research, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2014 December 31st | 2015 December 31st | 2016 December 31st | 2017 December 31st | 2018 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 1.47 | 0.357 | 0.472 | 0.971 | 3.46 |
| Net Total Receivables | — | 0.012 | — | — | — |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1.49 | 0.408 | 0.482 | 1.04 | 3.52 |
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.029 | 0.023 | 0.015 | 0.016 | 0.037 |
| Total Assets | 1.52 | 0.43 | 0.497 | 1.06 | 3.55 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.06 | 0.108 | 0.146 | 0.27 | 0.438 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.06 | 0.108 | 0.396 | 0.27 | 10.8 |
| Redeemable Preferred Stock | |||||
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 1.46 | 0.323 | 0.101 | 0.791 | -7.21 |
| Total Liabilities & Shareholders' Equity | 1.52 | 0.43 | 0.497 | 1.06 | 3.55 |
| Total Common Shares Outstanding |